These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


156 related items for PubMed ID: 29945135

  • 1. Gaucher Disease and Myelofibrosis: A Combined Disease or a Misdiagnosis?
    Mariani S, Palumbo G, Cardarelli L, Santopietro M, Foà R, Giona F.
    Acta Haematol; 2018; 139(4):240-242. PubMed ID: 29945135
    [Abstract] [Full Text] [Related]

  • 2. Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management.
    Tefferi A.
    Am J Hematol; 2016 Dec; 91(12):1262-1271. PubMed ID: 27870387
    [Abstract] [Full Text] [Related]

  • 3. Primary myelofibrosis: 2014 update on diagnosis, risk-stratification, and management.
    Tefferi A.
    Am J Hematol; 2014 Sep; 89(9):915-25. PubMed ID: 25124313
    [Abstract] [Full Text] [Related]

  • 4. Primary myelofibrosis: 2013 update on diagnosis, risk-stratification, and management.
    Tefferi A.
    Am J Hematol; 2013 Feb; 88(2):141-50. PubMed ID: 23349007
    [Abstract] [Full Text] [Related]

  • 5. Clinical utility of different bone marrow examination methods in the diagnosis of adults with sporadic Gaucher disease type 1.
    Machaczka M, Markuszewska-Kuczyńska A, Regenthal S, Jurczyszyn A, Gałązka K, Wahlin BE, Klimkowska M.
    Pol Arch Med Wewn; 2014 Feb; 124(11):587-92. PubMed ID: 25188399
    [Abstract] [Full Text] [Related]

  • 6. Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management.
    Tefferi A.
    Am J Hematol; 2011 Dec; 86(12):1017-26. PubMed ID: 22086865
    [Abstract] [Full Text] [Related]

  • 7. [Gaucher disease--one of the possible causes of splenomegaly--case report].
    Sokołowska B, Skomra D, Czartoryska B, Tomczak W, Tylki-Szymańska A, Repelewska M, Drop A, Gromek T.
    Pol Arch Med Wewn; 2004 Sep; 112(3):1107-12. PubMed ID: 15727093
    [Abstract] [Full Text] [Related]

  • 8. Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis.
    Bae E, Park CJ, Cho YU, Seo EJ, Chi HS, Jang S, Lee KH, Lee JH, Lee JH, Suh JJ, Im HJ.
    Int J Lab Hematol; 2013 Dec; 35(6):629-36. PubMed ID: 23693053
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neuronopathic Gaucher disease presenting with microcytic hypochromic anemia.
    Kim EA, Lim YT, Hah JO, Sohn YB, Kim YK, Choi JH, Kim SY, Jang KM, Ahn J, Lee JM.
    Int J Hematol; 2019 Mar; 109(3):361-365. PubMed ID: 30456712
    [Abstract] [Full Text] [Related]

  • 13. An Unexpected Finding of Hepatosplenomegaly in a Pediatric Patient.
    Barootes HC, Prasad C, Rupar CA, Ashok D.
    Clin Pediatr (Phila); 2022 Jan; 61(1):81-85. PubMed ID: 34789027
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy in a patient with chronic neuronopathic Gaucher disease: a case report.
    Ceravolo F, Grisolia M, Sestito S, Falvo F, Moricca MT, Concolino D.
    J Med Case Rep; 2017 Jan 20; 11(1):19. PubMed ID: 28103924
    [Abstract] [Full Text] [Related]

  • 15. Combined miglustat and enzyme replacement therapy in two patients with type 1 Gaucher disease: two case reports.
    Amato D, Patterson MA.
    J Med Case Rep; 2018 Jan 27; 12(1):19. PubMed ID: 29373994
    [Abstract] [Full Text] [Related]

  • 16. Recent advances in the diagnosis and management of primary myelofibrosis.
    Takenaka K, Shimoda K, Akashi K.
    Korean J Intern Med; 2018 Jul 27; 33(4):679-690. PubMed ID: 29665657
    [Abstract] [Full Text] [Related]

  • 17. Molecular Pathogenesis and Clinical Significance of Driver Mutations in Primary Myelofibrosis: A Review.
    Alshemmari SH, Rajan R, Emadi A.
    Med Princ Pract; 2016 Jul 27; 25(6):501-509. PubMed ID: 27756071
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis.
    Yönal İ, Dağlar-Aday A, Akadam-Teker B, Yılmaz C, Nalçacı M, Yavuz AS, Sargın FD.
    Turk J Haematol; 2016 Jun 05; 33(2):94-101. PubMed ID: 25913509
    [Abstract] [Full Text] [Related]

  • 20. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
    Mazher W, Ali J, Abubakar S, Basar S, Murtaza G.
    J Ayub Med Coll Abbottabad; 2018 Jun 05; 30(3):479-481. PubMed ID: 30465391
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.